The US Food and Drug Administration made a significant announcement on Thursday regarding Juul Labs Inc.’s vaping products. The FDA disclosed that it has lifted the marketing ban on Juul’s vaping devices and pods. However, the ultimate fate of these products in the market is still pending a final decision from the regulatory body.

Following the FDA’s decision, Juul confirmed that its products will continue to be available for purchase while undergoing a thorough scientific review process. This move comes after the FDA had initially imposed a marketing ban on Juul products in 2022, encompassing devices and tobacco as well as menthol-flavored pods. The ban was temporarily halted shortly after its implementation due to unresolved scientific concerns.

The recent development by the FDA to rescind the marketing ban on Juul products is not tantamount to an approval or rejection of the products. It signifies a pivotal moment in the ongoing evaluation process, with the FDA emphasizing the necessity for all e-cigarette products, including those manufactured by Juul, to obtain FDA authorization for lawful marketing.

In response to the FDA’s decision, Juul expressed its readiness to collaborate with the agency in a data-driven approach to secure marketing authorization for its products. Meanwhile, the American Lung Association expressed deep concern over the FDA’s actions, highlighting Juul’s role in the youth e-cigarette epidemic and advocating for stringent regulatory measures.

As the FDA continues its review process, stakeholders in the vaping industry and public health advocates await further developments to ascertain the future status of Juul’s products in the market.